For over three decades, CEI has advocated health care reforms that put more power in the hands of consumers to choose their health providers, treatment protocols, and scope of insurance coverage. We have advocated reform of the Food and Drug Administration’s drug and device approval process to allow for greater flexibility and patient choice. And in 2013, CEI organized the court challenges to Obamacare’s exchange subsidies that concluded with the Supreme Court’s King v. Burwell decision.
Healthcare Issue Areas
Featured Posts
News Release
Rescheduling marijuana to a less restrictive category will benefit liberty and public health
President Trump signed an executive order today intended to fast track the rescheduling of cannabis from a Schedule I substance, the same as heroin,…
News Release
CEI Study: Government laws against pharmacy ownership would increase costs, restrict access for consumers
Innovation is reshaping how Americans get their prescription medications. Whether picking up medications in person, ordering online, or getting same-day delivery from services like Capsule,…
Study
A Free Market is the Best Medicine
Introduction The pharmaceutical supply market is seeing extraordinarily high levels of innovation and consumer-benefiting evolution. The combination of a competitive market for generic drugs, rapid…
Search Posts
Op-Eds
Is Bailout The Best Remedy?
Gattuso Op-Ed in The Washington Times<?xml:namespace prefix = o ns = “urn:schemas-microsoft-com:office:office” /> Before the tragedies of Sept.
Op-Eds
A Crashing Failure: The Stupid Tragedy of CAFE
Provided courtesy of www.nationalreview.com/ If the National Academy of Sciences discovered that a certain chemical was killing several…
Citation
Resort to False Fuel Savings
Op-Eds
Dangerous GM Gets Off Scot-Free
Conko and Miller Op-Ed in The Wall Street Journal Europe<?xml:namespace prefix = o ns = “urn:schemas-microsoft-com:office:office” /> …
Products
Life, Liberty, And Cell Phones
From the August 2001 Edition of CEI Update A car speeds down a busy highway, zigzagging unpredictably from lane to…
Op-Eds
Cutting Regulation From the EPA: Gene-splicing Policy Should Be Excised
Miller Op-Ed in The Washington TImes Miller Op-Ed in The Washington Times A persistent criticism of the…